XML 72 R63.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies, Contingent Consideration and Milestone Payments (Details)
$ in Thousands
1 Months Ended 9 Months Ended
Jan. 31, 2022
USD ($)
Device
Jan. 31, 2022
USD ($)
Sep. 30, 2024
USD ($)
Development Agreement [Member] | Maximum [Member]      
Contingent Consideration and Milestone Payments [Abstract] [Abstract]      
Future earnout payments $ 500 $ 500  
Future earnout payment due upon revenue target 500 500  
Future milestone payments $ 3,000 3,000  
Number of devices in development | Device 3    
Development agreement term     3 years
TheraClear Corporation [Member]      
Contingent Consideration and Milestone Payments [Abstract] [Abstract]      
Future earnout payment due upon revenue target $ 1,000 1,000  
Subsequent period of gross profit for future royalty payments     4 years
Royalty and gross profit payments incurred     $ 122
TheraClear Corporation [Member] | Maximum [Member]      
Contingent Consideration and Milestone Payments [Abstract] [Abstract]      
Future earnout payments 3,000 3,000  
Future royalty payments 20,000 20,000  
Future milestone payments $ 500 $ 500  
TheraClear Corporation [Member] | Domestic [Member] | Minimum [Member]      
Contingent Consideration and Milestone Payments [Abstract] [Abstract]      
Percentage of gross profit for future royalty payments for subsequent period   10.00%  
TheraClear Corporation [Member] | Domestic [Member] | Maximum [Member]      
Contingent Consideration and Milestone Payments [Abstract] [Abstract]      
Percentage of gross profit for future royalty payments for subsequent period   20.00%  
TheraClear Corporation [Member] | International [Member]      
Contingent Consideration and Milestone Payments [Abstract] [Abstract]      
Percentage of gross profit for future royalty payments for subsequent period   25.00%